title: Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.
authors.affiliation: Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, España. Electronic address: jmarcoval@bellvitgehospital.cat.
authors.forename: J
authors.initials: J
authors.lastname: Marcoval
authors.affiliation: Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, España.
authors.forename: J
authors.initials: J
authors.lastname: Notario
authors.affiliation: Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, España.
authors.forename: C
authors.initials: C
authors.lastname: Martín
authors.affiliation: Servicio de Dermatología, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, España.
authors.forename: S
authors.initials: S
authors.lastname: Gómez
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D016898:Interferon-alpha / Q000009:adverse effects*; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced*; D012254:Ribavirin / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin